Results 191 to 200 of about 78,829 (264)

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin

Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 2, August 2026.
ABSTRACT The 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A reductase inhibitor rosuvastatin is a substrate of breast cancer resistance protein (BCRP). BCRP inhibition increases rosuvastatin plasma concentrations and may result in concentration‐dependent muscle toxicity, at worst rhabdomyolysis.
Ronja Levomäki, Päivi Hirvensalo, Aleksi Tornio, Anne M. Filppula   +3 more
wiley   +1 more source

Real-world therapeutic trajectories in pustular psoriasis: Outcomes and relapse patterns in a low-resource health system. [PDF]

JAAD Int
Espitia-Hernandez D, Peñaranda-Contreras E, Cortes-Correa C.   +2 more
europepmc   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle, Kiersten Ricci, Kelly Blache, Rebecca A. Marsh, Adrienne M. Hammill, Elissa Engel   +5 more
wiley   +1 more source

Nummular Keratitis Following Epidemic Keratoconjunctivitis: A Guide to Managing Subepithelial Infiltrates. [PDF]

Cureus
Y K, P M, Anna Koshy S.
europepmc   +1 more source

Risk Factors for Small‐for‐Size Syndrome Grade B/C After Simultaneous Splenectomy in Adult Living‐Donor Liver Transplantation

Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1165-1173, July 2026.
In a single‐center cohort of 577 adult LDLT recipients who underwent simultaneous splenectomy, clinically significant SFSS grade B/C (ILTS‐iLDLT‐LTSI 2023) occurred in 18.2% and was associated with inferior graft survival. Multivariate analysis identified MELD ≥ 30, NLR ≥ 4.5, and donor age ≥ 50 years as independent risk factors, which risk rising ...
Kyohei Yugawa, Takeo Toshima, Shinji Itoh, Takashi Motomura, Shohei Yoshiya, Norifumi Iseda, Tomoharu Yoshizumi   +6 more
wiley   +1 more source

Dupilumab-induced generalized pustular psoriasis in an elderly patient: a case report and literature review. [PDF]

An Bras Dermatol
Lee S, Lai FYX, Lee S.
europepmc   +1 more source

Personalized Treatment Outcomes in Idiopathic Granulomatous Mastitis: A Retrospective Study of Ninety-Two Patients. [PDF]

Eur J Breast Health
Jafarov R, Aliyev A, Babazade I, Abdullayeva R, Sharifova K, Asadov N, Samedov E.   +6 more
europepmc   +1 more source

Successful Treatment of Oxaliplatin-Induced Immune Thrombocytopenia in a Schizophrenic Patient With Contraindication to Steroids Using Cyclosporine Plus Eltrombopag: A Case Report. [PDF]

Case Rep Med
Zheng J, Zhou N, Pang D, Zhou S, Zheng H.   +4 more
europepmc   +1 more source

Serum proteomic changes in atopic dermatitis patients treated with cyclosporine. [PDF]

PLoS One
Olydam JI, Litman T, Nijsten T, Hoof I, Koopmann W, Pardo LM, Hijnen D.   +6 more
europepmc   +1 more source

Two-Hour Post-dose (C2)-Monitored Cyclosporine Microemulsion as a Practical Alternative to Voclosporin in Mixed Class IV/V Lupus Nephritis: A Case Report. [PDF]

Cureus
Akella D, Ramoutar V.
europepmc   +1 more source